Tuberculosis (TB) is the second most common cause of death due to an infectious disease. Among all new TB cases notified to federal ministry of health, 30% were smear positive. Among re-treatment cases 64%, 11% and 13% were relapse, treatment after failure, and treatment after default respectively. The directly observed treatment short course detection rate remains low, at 34%, compared with WHOs target of 70%. The emergence and spread of DR-TB strains on new and previously treated cases have been a global threat. Worldwide, 3.7% of new cases and 20% of previously treated cases were estimated to have multi drug resistance-tuberculosis (MDR-TB). Extensively drugresistant tuberculosis (XDR- TB) has been reported in more than 70 countries. The proportion of MDR-TB patients who successfully completed treatment and cured were lowered than drug susceptible forms of TB. MDR-TB associated deaths were more worsen in the African Region (19%), where many of the diagnostic and treatment facilities were limited or totally absent.
Last date updated on January, 2021